Merel Ritskes-Hoitinga will be SYRCLE's representative on the ESI Board.SYRCLE will be a formal member of the Board of Directors of Evidence Synthesis International (ESI), an organization formed in 2016 to bring organisations that produce and use evidence syntheses around the world together to build capacity, share resources, and advocate for evidence syntheses and their use in policy and practice decision making.
The Board of Directors will be comprised of eight organisations, supported by two co-chairs (Jeremy Grimshaw and David Gough) and the Secretariat (Hans Lund and Jennifer Yost). There are existing five sub-committees.
Merel Ritskes-Hoitinga is member of the theme Reconstructive and regenerative medicine.
Related news items
Regional hospitals invest in joint research Four new projects have been granted29 October 2020
Four more research projects have been granted in the promotion fund of the Radboudumc and the regional hospitals.read more
Two studies show potential of trained immunity for the treatment of cancer Radboudumc makes Cell twice in one issue29 October 2020
Mihai Netea: "These studies show that stimulating trained immunity can have an important anti-cancer effect. In combination with current immunotherapy with 'checkpoint inhibitors', boosting trained immunity has the potential to significantly improve cancer treatment"read more
Research should facilitate discontinuation of antidepressants29 October 2020
How do you reduce the use of antidepressants safely and without major problems? That is a question that concerns many patients and physicians. Radboudumc and Amsterdam UMC in the Netherlands are going to investigate this with a ZonMw grant of 1.5 million euros.read more
Cum Laude PhD defense for Vincent Aengevaeren29 October 2020
We congratulate Vincent Aengevaeren! After defending his thesis entitled: ‘Potential Detrimental Effects of Exercise on the Heart’ on 28 October, Vincent attained his PhD degree with honors. Vincent had been appointed on a RIHS Junior Researcher grant.read more
Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation28 October 2020
A multidisciplinary team of RIMLS and Radboud University researchers published in Advanced Science that Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation.read more